Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - ImmunoGen, Inc. | imgn-20200331xex31d1.htm |
| 10-Q - 10-Q - ImmunoGen, Inc. | imgn-20200505x10q.htm |
| EX-10.1 - EX-10.1 - ImmunoGen, Inc. | imgn-20200331xex10d1.htm |
EXHIBIT 32
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ImmunoGen, Inc., a Massachusetts corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report for the period ended March 31, 2020 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: May 5, 2020 |
/s/MARK J. ENYEDY |
|
|
Mark J. Enyedy |
|
|
President, Chief Executive Officer |
|
|
(Principal Executive Officer and |
|
|
|